Sanuwave Health (SNWV) reported second-quarter fiscal 2026 revenue of $9.7 million for the three months ended June 30, down 3% from $10.1 million in the year-ago quarter. GAAP net loss was $0.7 million, compared with net income of $0.6 million in Q2 2025.
The company said it sold 82 Ultramist systems in Q2 2026, down from 116 in Q2 2025 and 97 in Q1 2026. Ultramist applicator revenue rose 13% to $7.3 million, while gross margin was 76.2% versus 78.1% a year earlier.
- Q2 2026 revenue was $9.7 million, compared with $10.1 million in Q2 2025.
- GAAP operating loss was $0.3 million, compared with operating income of $1.4 million a year earlier.
- Net loss was $0.7 million, compared with net income of $0.6 million in Q2 2025.
- Adjusted EBITDA was $1.2 million, compared with $3.2 million in the prior-year quarter.
- Sanuwave withdrew its previously issued fiscal 2026 guidance, citing market conditions and Medicare reimbursement developments.
- The company scheduled a business update conference call for August 7, 2026.
$SNWV Insider Trading Activity
$SNWV insiders have traded $SNWV stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $SNWV stock by insiders over the last 6 months:
- MANAGEMENT INC. OPALEYE has made 0 purchases and 11 sales selling 122,698 shares for an estimated $2,186,192.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SNWV Hedge Fund Activity
We have seen 25 institutional investors add shares of $SNWV stock to their portfolio, and 32 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 191,642 shares (+1029.2%) to their portfolio in Q1 2026, for an estimated $3,313,490
- PRAETORIAN PR LLC added 85,000 shares (+32.1%) to their portfolio in Q1 2026, for an estimated $1,469,650
- EVERSOURCE WEALTH ADVISORS, LLC removed 43,054 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $430,540
- HUNTLEIGH ADVISORS, INC. removed 33,445 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $578,264
- RICE HALL JAMES & ASSOCIATES, LLC removed 25,156 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $434,947
- MILLENNIUM MANAGEMENT LLC added 24,669 shares (+inf%) to their portfolio in Q1 2026, for an estimated $426,527
- JANE STREET GROUP, LLC removed 19,666 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $340,025
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
